WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

CINCINNATI (WKRC) — As summer draws to a close, AstraZeneca has introduced a new way to fight the flu with the launch of FluMist Home, the first-ever home-administered flu vaccine. This innovative ...

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...

AstraZeneca is facing some headwinds related to its operations in China. Still, the company's financial results and pipeline look strong. The stock could deliver solid returns for those who invest at ...

AstraZeneca has refuted allegations its staff “refuse to cooperate and respect” the U.K. marketing code. The drugmaker successfully defended itself against claims senior staff ignored requests to ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

(Alliance News) - AstraZeneca PLC on Sunday said Imfinzi has been approved in the EU as the first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers. The ...

AstraZeneca has succumbed to pressure from US president Donald Trump to reduce the cost of its medications for American patients. The Cambridge-headquartered pharmaceutical giant announced it will ...